Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis.

Na-Bangchang, Kesara; Ahmed, Oumer; Hussein, Jemal; Hirayama, Kenji; Kongjam, Panida; Aseffa, Abraham; Karbwang, Juntra

Na-Bangchang, Kesara; Ahmed, Oumer; Hussein, Jemal; Hirayama, Kenji; Kongjam, Panida; Aseffa, Abraham; Karbwang, Juntra.

Afiliação

Na-Bangchang K; Graduate Studies, Chulabhorn International College of Medicine, Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Thammasat University, Pathum Thani 12121, Thailand.
Ahmed O; Armauer Hansen Research Institute (AHRI), 1000 Addis Ababa, Ethiopia.
Hussein J; Armauer Hansen Research Institute (AHRI), 1000 Addis Ababa, Ethiopia.
Hirayama K; Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
Kongjam P; Graduate Studies, Chulabhorn International College of Medicine, Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Thammasat University, Pathum Thani 12121, Thailand.
Aseffa A; Armauer Hansen Research Institute (AHRI), 1000 Addis Ababa, Ethiopia.
Karbwang J; Clinical Product Development, Institute of Tropical Medicine (NEKKEN), Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Evid Based Complement Alternat Med ; 2016: 5984709, 2016.

Article em En | MEDLINE | ID: mdl-27195014

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Tailândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google